RPS23P6

Across TCGA pan-cancer cohorts, RPS23P6 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated RPS23P6 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RPS23P6 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPS23P6 expression acts as an unfavorable survival marker, although some lineages such as LUSC and READ show a favorable association.

KIRC, LUSC, and UVM are the cancer types where RPS23P6 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.468	0.750	<.001	73	view →
LUSC	DFS	Median	III,IV	0.702	0.389	<.001	63	view →
UVM	OS	Tertile	All	0.426	0.947	.003	48	view →
READ	OS	Tertile	III,IV	0.724	0.274	.003	30	view →
PAAD	OS	Tertile	All	0.554	0.256	.004	28	view →
THCA	OS	Median	All	0.846	1.000	.011	21	view →
SKCM	OS	Median	II,III,IV	0.799	0.680	.018	15	view →
LIHC	DFS	Quartile	All	0.168	0.397	.002	13	view →
DLBC	OS	Tertile	II,III,IV	0.267	1.000	.013	11	view →
MESO	DFS	Median	All	0.598	0.293	.037	9	view →
LGG	OS	Quartile	All	0.799	0.921	.007	8	view →
ACC	OS	Tertile	IV	0.371	1.000	.024	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

RPS23P6–KIRC (OS)

Open the KIRC breakdown →